Chief Scientific Officer
Sanjay has over 20 years of experience in drug development, including experience with product development, regulatory affairs, and product registration. Most recently, Sanjay served as Senior Vice President, Drug Development at Anacor Pharmaceuticals until its acquisition by Pfizer in June of 2016. He also held industry positions at NeurogesX, Cerus Corporation and PPD-Development.
Sanjay received his PhD. in Pharmacology/Toxicology at Northeast Louisiana University and completed postdoctoral fellowships at University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina.